Science Explorer Back to mapMap
Discussion
Researcher · CeMM Research Center for Molecular Medicine · Austria

Thomas Krausgruber

Thomas Krausgruber publishes mostly in Immunology, Molecular Biology and Oncology, on topics such as Immune Cell Function and Interaction, T-cell and B-cell Immunology and Single-cell and spatial transcriptomics.

ORCID 0000-0002-1374-0329 OpenAlex
World rank
#73,958
of 7,710,434 ranked researchers
Rank in Austria
#711
of 43,330
Works
106
Citations
9.2k
Citations per work
86.6
h-index
36
i10-index 54Top 9.8% in Immunology
Thomas Krausgruber

What does Thomas Krausgruber research?

Thomas Krausgruber's work is mostly in Immunology and Microbiology (42%), Biochemistry, Genetics and Molecular Biology (17%), Medicine (16%).

Life Sciences: 62 works · 58.8% of their workImmunology and Microbiology: 45 works · 42.3% of their workImmunology: 45 works · 42.3% of their workBiochemistry, Genetics and Molecular Biology: 17 works · 16.5% of their workMolecular Biology: 17 works · 16.5% of their workEverything else: 27 works · 25.7% of their workHealth Sciences: 16 works · 15.5% of their workMedicine: 16 works · 15.5% of their workOncology: 5 works · 4.6% of their workPhysiology: 5 works · 4.6% of their workDermatology: 4 works · 3.5% of their workSurgery: 3 works · 2.8% of their workTHEIR WORKThomasKrausgruber106works
Life Sciences59%Health Sciences16%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology4542.3%
    2. Biochemistry, Genetics and Molecular Biology1716.5%
  2. Everything else2725.7%
    1. Medicine1615.5%
  1. 1Immunology42% of their works
  2. 2Molecular Biology16% of their works
  3. 3Oncology5% of their works
  4. 4Physiology5% of their works
  5. 5Dermatology4% of their works
  6. 6Surgery3% of their works

Research topics

Which keywords describe Thomas Krausgruber's research?

The keywords of their largest research topics: Natural Killer Cells, NK Cell Recognition, Foxp3, TGF-ß, Inflammation, IL-33, Innate Lymphoid Cells and Single-Cell.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. NK Cell Recognition291 topic
  2. Natural Killer Cells291 topic
  3. Foxp3181 topic
  4. TGF-ß181 topic
  5. Inflammation172 topics
  6. IL-33161 topic
  7. Innate Lymphoid Cells161 topic
  8. Single-Cell161 topic
  9. Transcriptomics161 topic
  10. Pattern Recognition Receptors152 topics
  11. Activation91 topic
  12. Macrophage91 topic
  13. Innate Antiviral Responses81 topic
  14. Innate Memory81 topic
  15. Toll-like Receptors81 topic
  16. Trained Immunity81 topic
  17. Innate Immunity71 topic
  18. Viral Infection71 topic

Where does Thomas Krausgruber work?

Thomas Krausgruber's main affiliation in the publication record is CeMM Research Center for Molecular Medicine, Austria.

How many publications and citations does Thomas Krausgruber have?

OpenAlex counts 106 works and 9,178 citations for Thomas Krausgruber, an h-index of 36, ranking #73,958 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Thomas Krausgruber. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.